If you are a health care professional and are interested in more information regarding Mutaflor please contact us at info@inovera.com

History of Mutaflor

• Discovered in 1917 by Professor Alfred Nissle.
• Subsequent research showed that this strain of E. coli Nissle 1917 has a large number of beneficial qualities and is helpful therapeutically and prophylactically in inflammatory and functional bowel diseases.
• North American rights obtained by Medical Futures, Inc., and INOVERA Bioscience, Inc. selected as US distributor in 2010.

Properties of Mutaflor

• E. coli strain Nissle 1917 helps to establish health promoting gut flora by acting against pathogenic bacteria.

• Stabilizes the intestinal epithelial barrier

• Regulates the gut-associated lymphoid tissue (GALT), areas of the gut containing large amounts of immune system cells.

• E. coli strain Nissle 1917 also has gut motility regulating properties.

Suggested Use

Mutaflor is a medical food that is intended to be used under the supervision of a physician for the dietary management of ulcerative colitis (UC).

For references to published clinical studies click on this link: http://mutaflor.ca/health-care-professionals/mutaflor-clinical-studies/